Title: Simultaneous determination of antidementia drugs in human plasma: procedure transfer from HPLC-MS to UPLC-MS/MS.
Journal: Journal of pharmaceutical and biomedical analysis 20120501
Title: Concentrations of rivastigmine and NAP 226-90 and the cognitive response in Taiwanese Alzheimer's disease patients.
Journal: Journal of Alzheimer's disease : JAD 20120101
Title: Spectrophotometric and spectrodensitometric methods for the determination of rivastigmine hydrogen tartrate in presence of its degradation product.
Journal: Drug testing and analysis 20100501
Title: Simultaneous determination of galantamine, rivastigmine and NAP 226-90 in plasma by MEKC and its application in Alzheimer's disease.
Journal: Electrophoresis 20090201
Title: Pharmacokinetics and bioavailability of the novel rivastigmine transdermal patch versus rivastigmine oral solution in healthy elderly subjects.
Journal: Journal of clinical pharmacology 20080201
Title: Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients.
Journal: Clinical pharmacology and therapeutics 20080101
Title: Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease not affected by co-administration of memantine: an open-label, crossover, single-centre study.
Journal: Clinical drug investigation 20080101
Title: A simple and sensitive assay for the quantitative analysis of rivastigmine and its metabolite NAP 226-90 in human EDTA plasma using coupled liquid chromatography and tandem mass spectrometry.
Journal: Rapid communications in mass spectrometry : RCM 20060101
Title: A simple, rapid and sensitive method for simultaneous determination of rivastigmine and its major metabolite NAP 226-90 in rat brain and plasma by reversed-phase liquid chromatography coupled to electrospray ionization mass spectrometry.
Journal: Biomedical chromatography : BMC 20040401
Title: Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine.
Journal: Biochemistry 20020319
